Facial Onset Sensory and Motor Neuronopathy: A Case Series and Literature Review
DOI:
https://doi.org/10.17161/rrnmf.v4i2.18692Keywords:
FOSMN, Facial Onset Sensory and Motor Neuronopathy, Neurodegenerative disordersAbstract
Introduction: Facial Onset Sensory and Motor Neuronopathy (FOSMN) typically presents with paresthesias in the trigeminal nerve distribution and weakness that progresses rostro-caudally.
Objective: To present two new cases of FOSMN, summarize the current literature, and address areas for future study.
Methods: Observational data was collected from two patients with FOSMN from our institution. A literature review of FOSMN was completed using PubMed.
Results: We identified 100 cases of FOSMN, including our two new cases. 93% presented with facial paresthesias. 97% had bulbar symptoms. Five had family history of ALS. Abnormal Blink reflex was most common on EMG/NCS. CSF was typically normal, but a rare severe case showed elevated protein. Mutations included: TARDBP, OPMD, D90A-SOD1, CHCHD10, VCP, and SQSTM1. Neuropathological studies showed neurodegenerative changes without inflammation. Some cases have reported transient stabilization or improvement to immunomodulatory therapy.
Case Reports: A 72-year-old man presented with right-sided trigeminal paresthesias that progressed in a rostro-caudal fashion, dysphagia, and hand weakness. He died 4-5 years after symptom onset. A 69-year-old man presented with left-sided jaw paresthesias, dysphagia and dysarthria. He was trialed on IVIG for 1.5 years without improvement and died 2.6 years after symptom onset.
Conclusion: FOSMN is a rare disorder with a unique clinical and electrophysiological phenotype. The pathophysiology has been associated with neurodegeneration and multiple gene mutations have correlated to FOSMN. Some reports suggest transient response to immunomodulatory therapy, though prospective studies are lacking. CSF protein elevation may be seen in severe disease. Future studies will help further elucidate the approach to diagnosis, treatment, and prognostic counseling (biomarkers).
Metrics
Downloads
References
Vucic S, Tian D, Chong PS, Cudkowicz ME, Hedley-Whyte ET, Cros D. Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology. Brain. Dec 2006;129(Pt 12):3384-90. doi:10.1093/brain/awl258
Zheng Q, Chu L, Tan L, Zhang H. Facial onset sensory and motor neuronopathy. Neurol Sci. Dec 2016;37(12):1905-1909. doi:10.1007/s10072-016-2686-7
Karakis I, Vucic S, Srinivasan J. Facial onset sensory and motor neuronopathy (FOSMN) of childhood onset. Muscle Nerve. Oct 2014;50(4):614-5. doi:10.1002/mus.24299
Rossor AM, Jaunmuktane Z, Rossor MN, Hoti G, Reilly MM. TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMN. Neurology. 02 26 2019;92(9):e951-e956. doi:10.1212/WNL.0000000000007008
Broad R, Leigh PN. Recognising facial onset sensory motor neuronopathy syndrome: insight from six new cases. Pract Neurol. Aug 2015;15(4):293-7. doi:10.1136/practneurol-2014-000984
Knopp M, Vaghela NN, Shanmugam SV, Rajabally YA. Facial onset sensory motor neuronopathy: an immunoglobulin-responsive case. J Clin Neuromuscul Dis. Jun 2013;14(4):176-9. doi:10.1097/CND.0b013e31828ee8fe
Ferrari G, Grisan E, Scarpa F, et al. Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis. Front Aging Neurosci. 2014;6:278. doi:10.3389/fnagi.2014.00278
Wimmer T, Schreiber F, Hensiek N, et al. The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI. Sci Rep. 02 04 2020;10(1):1783. doi:10.1038/s41598-020-58687-z
Vucic S, Stein TD, Hedley-Whyte ET, et al. FOSMN syndrome: novel insight into disease pathophysiology. Neurology. Jul 03 2012;79(1):73-9. doi:10.1212/WNL.0b013e31825dce13
Dalla Bella E, Rigamonti A, Mantero V, et al. Heterozygous D90A-SOD1 mutation in a patient with facial onset sensory motor neuronopathy (FOSMN) syndrome: a bridge to amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. Sep 2014;85(9):1009-11. doi:10.1136/jnnp-2013-307416
Ohashi N, Nonami J, Kodaira M, Yoshida K, Sekijima Y. Taste disorder in facial onset sensory and motor neuronopathy: a case report. BMC Neurol. Feb 29 2020;20(1):71. doi:10.1186/s12883-020-01639-x
Ziso B, Williams TL, Walters RJ, et al. Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy. Case Rep Neurol. 2015 Jan-Apr 2015;7(1):95-100. doi:10.1159/000381944
Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol. Feb 2016;23(2):416-20. doi:10.1111/ene.12936
Pinto WBVR, Naylor FGM, Chieia MAT, de Souza PVS, Oliveira ASB. New findings in facial-onset sensory and motor neuronopathy (FOSMN) syndrome. Rev Neurol (Paris). Apr 2019;175(4):238-246. doi:10.1016/j.neurol.2018.04.010
de Boer EMJ, Barritt AW, Elamin M, et al. Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and Pathophysiology. Neurol Clin Pract. Apr 2021;11(2):147-157. doi:10.1212/CPJ.0000000000000834
Hokonohara T, Shigeto H, Kawano Y, Ohyagi Y, Uehara M, Kira J. Facial onset sensory and motor neuronopathy (FOSMN) syndrome responding to immunotherapies. J Neurol Sci. Dec 15 2008;275(1-2):157-8. doi:10.1016/j.jns.2008.07.021
Vázquez-Costa JF, Pedrola Vidal L, Moreau-Le Lan S, et al. Facial onset sensory and motor neuronopathy: a motor neuron disease with an oligogenic origin? Amyotroph Lateral Scler Frontotemporal Degener. 05 2019;20(3-4):172-175. doi:10.1080/21678421.2019.1582671
Fluchere F, Verschueren A, Cintas P, et al. Clinical features and follow-up of four new cases of facial-onset sensory and motor neuronopathy. Muscle Nerve. Jan 2011;43(1):136-40. doi:10.1002/mus.21884
Dobrev D, Barohn RJ, Anderson NE, et al. Facial onset sensorimotor neuronopathy syndrome: a case series. J Clin Neuromuscul Dis. 09 2012;14(1):7-10. doi:10.1097/CND.0b013e31825f82b3
Sonoda K, Sasaki K, Tateishi T, et al. TAR DNA-binding protein 43 pathology in a case clinically diagnosed with facial-onset sensory and motor neuronopathy syndrome: an autopsied case report and a review of the literature. J Neurol Sci. Sep 15 2013;332(1-2):148-53. doi:10.1016/j.jns.2013.06.027
Agirre-Beitia G, Moreno-Estébanez A, González-Pinto González T, et al. FOSMN: A possible TDP-43 proteinopathy to consider in a patient with facial sensory symptoms. Neurol Clin Pract. Oct 2020;10(5):e47-e50. doi:10.1212/CPJ.0000000000000753
Pinto WBVR, Debona R, Nunes PP, et al. Atypical Motor Neuron Disease variants: Still a diagnostic challenge in Neurology. Rev Neurol (Paris). Apr 2019;175(4):221-232. doi:10.1016/j.neurol.2018.04.016
Zhang Q, Cao B, Chen Y, et al. Facial Onset Motor and Sensory Neuronopathy Syndrome With a Novel TARDBP Mutation. Neurologist. Jan 2019;24(1):22-25. doi:10.1097/NRL.0000000000000201
Cruccu G, Pennisi EM, Antonini G, et al. Trigeminal isolated sensory neuropathy (TISN) and FOSMN syndrome: despite a dissimilar disease course do they share common pathophysiological mechanisms? BMC Neurol. Dec 19 2014;14:248. doi:10.1186/s12883-014-0248-2
Truini A, Provitera V, Biasiotta A, et al. Differential trigeminal myelinated and unmyelinated nerve fiber involvement in FOSMN syndrome. Neurology. Feb 03 2015;84(5):540-2. doi:10.1212/WNL.0000000000001216
Watanabe M, Shiraishi W, Yamasaki R, et al. Oral phase dysphagia in facial onset sensory and motor neuronopathy. Brain Behav. 06 2018;8(6):e00999. doi:10.1002/brb3.999
Yamamoto D, Yamada M, Cao B, Suzuki S, Hisahara S, Shimohama S. [A case of facial-onset sensory and motor neuronopathy (FOSMN) with cerebellar ataxia and abnormal decrement in repetitive nerve stimulation test]. Rinsho Shinkeigaku. Feb 23 2021;61(2):115-119. doi:10.5692/clinicalneurol.cn-001508
Lecky BR, Hughes RA, Murray NM. Trigeminal sensory neuropathy. A study of 22 cases. Brain. Dec 1987;110 ( Pt 6):1463-85. doi:10.1093/brain/110.6.1463
Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain. Nov 2005;128(Pt 11):2518-34. doi:10.1093/brain/awh605
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Jonathan Morena DO, Hera Kamdar MD, Rabia Yasin MD, J. Chad Hoyle MD, Adam Quick MD, Stephen J. Kolb MD PhD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
